It refers to retatrutide, a tripleagonist weightloss medication that activates GLP1, GIP, and glucagon receptors. Early clinical trials show unprecedented weightloss results, often greater than currently approved GLP1 and dualagonist drugs, along with improvements in liver fat and metabolic markers. As research advances and more data become available, medically supervised programs will continue to evaluate where TRIPLEagonist medications fit among GLP1 drugs, dualagonists, peptides, and other tools for sustainable metabolic health
She is a resident doctor, researcher, and medical writer who believes in the importance of accessible, quality healthcare for everyone
Theyve inadvertently doubled their dose
Custom Designed Machines to Meet your Challenging Needs We understand your machine envelope constraints, retrofit ability requirements, interface connections, and maintenance requirements, and offer custom designed machines to meet your challenging needs
Persistent vomiting, inability to keep food or fluids down, or severe abdominal pain are not expected side effects
Obesity is a disease, and we need to treat it as such, Hurtado Andrade said